Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06152588 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Restricted Eating Time in the Treatment of Type 2 Diabetes

Study acronym: RESET2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 16, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Site details revisedv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Mar 21, 2024
    • Site details revised
    v3
  3. Start date: Jan 1, 2024 to Feb 1, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).
Trial Details
NCT Number NCT06152588
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: University of Leeds, Salk Institute for Biological Studies, University of Copenhagen, Glostrup University Hospital, Copenhagen
Conditions
(from sponsor)		 Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2, Fasting, Intermittent Fasting, Obesity, Overweight
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov